? If you bought Moderna (MRNA) early January, then at the moment would have tripled their investments. Only a few people have succeeded, so economically, this is another cash burner. Choice in the biotechnology sector is reminiscent of the job of a sapper, which is wrong once.
?It is for this reason that if you carry your flocks to this sector, and you are doing right, then you cannot do without specialized knowledge. In this article, the best minds will say, what medicines and developments can bring companies billions of green papers.
Novartis (NVS)
Novartis International came into being after the merger into 1996 year of 2 companies - Sandoz and Ciba.
Currently Novartis is the 2nd largest pharmaceutical company in the world after Pfizer , with branches in 140 States.
Basel headquarters (Switzerland). IN 2014 Novartis established a center in Hyderabad, India, to offshore some of our own research, clinical trials and administrative functions. Novartis also has 33,3 % shares of another pharmaceutical giant - Roche.
?Rate on Bimagrumab
Novo Nordisk (NVO)
Novo Nordisk is a pharmaceutical giant with almost a century of history and a focus on metabolic diseases. Additional indication of the product liragrutide, originally created to cure diabetes, to the healing of obesity, turned out to be indescribably successful. Only 2019 year, this product alone brought the company $852 million. Commercial name liragrutide for the treatment of obesity - Saxenda, and for type 2 diabetes - Victoza
?Rate on Cemaglutide + 4 product to reduce appetite
Amgen (AMGN)
Amgen Inc. (previously Applied Molecular Genetics Inc.) Is an American biopharmaceutical company headquartered in Thousand Oaks, California, where was founded in 1980 year.
Amgen is a company, focused on the application of existing technologies in its own arsenal in various therapeutic areas, including oncology, hematology and diseases, which are associated with inflammation. Amgen's total 14 drugs in the third phase of CI, three on the 2nd and more 20 on first
?Rate on AMG 171
Ionis (IONS)
Ionis Pharmaceuticals is a biotechnology company, based in Carlsbad, California. Specializes in finding and developing targeted RNA-based therapies.
Ionis already has three drugs, introduced to the market - Spinraza (for the treatment of spinal muscular atrophy, which we wrote about in the section about Novartis), Tegsedi and WAYLIVRA. Among the partners of the company - Biogen, Astra Zeneca and Roche.
?Rate on Ionia-PTP-1BRx
And for those, who has no time to read, explore and experiment, there is an index fund
IBB iShares Nasdaq Biotechnology ETF (IBB), in which there will be both Modern and Amgen.
